-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Pro-Dex, Inc. (NASDAQ:PDEX) Sees Large Growth in Short Interest
Pro-Dex, Inc. (NASDAQ:PDEX) Sees Large Growth in Short Interest
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating) saw a large growth in short interest in November. As of November 30th, there was short interest totalling 11,800 shares, a growth of 20.4% from the November 15th total of 9,800 shares. Based on an average trading volume of 9,000 shares, the short-interest ratio is presently 1.3 days. Currently, 0.5% of the company's stock are sold short.
Pro-Dex Stock Performance
Pro-Dex stock traded up $0.41 during midday trading on Friday, reaching $17.80. 887 shares of the company's stock were exchanged, compared to its average volume of 7,985. Pro-Dex has a 52 week low of $12.40 and a 52 week high of $26.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.39 and a current ratio of 2.73. The firm has a market cap of $63.72 million, a price-to-earnings ratio of 17.12 and a beta of 0.91. The stock's 50-day simple moving average is $18.07 and its 200 day simple moving average is $17.27.
Get Pro-Dex alerts:Wall Street Analyst Weigh In
Separately, StockNews.com assumed coverage on Pro-Dex in a report on Thursday. They set a "buy" rating for the company.
Hedge Funds Weigh In On Pro-Dex
Hedge funds and other institutional investors have recently bought and sold shares of the business. JPMorgan Chase & Co. boosted its holdings in shares of Pro-Dex by 59.2% during the first quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier's stock worth $345,000 after acquiring an additional 7,762 shares during the period. LSV Asset Management raised its position in shares of Pro-Dex by 13.9% in the first quarter. LSV Asset Management now owns 35,581 shares of the medical instruments supplier's stock valued at $588,000 after buying an additional 4,346 shares in the last quarter. State Street Corp raised its position in shares of Pro-Dex by 5.8% in the first quarter. State Street Corp now owns 11,923 shares of the medical instruments supplier's stock valued at $197,000 after buying an additional 650 shares in the last quarter. Renaissance Technologies LLC acquired a new stake in shares of Pro-Dex in the second quarter valued at approximately $168,000. Finally, Tower Research Capital LLC TRC raised its position in shares of Pro-Dex by 345.6% in the third quarter. Tower Research Capital LLC TRC now owns 2,687 shares of the medical instruments supplier's stock valued at $48,000 after buying an additional 2,084 shares in the last quarter. Institutional investors own 13.69% of the company's stock.About Pro-Dex
(Get Rating)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Read More
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- Which Two Bluechip Tech Companies Have Raised Their Guidance?
- Should You Worry About Elon Musk Selling His Tesla Shares?
- Can Tractor Supply Stock Surge Past Cup-With-Handle Buy Point?
- This is no Time to Buy Lennar but the Time is Coming
- Game-Changing News For Mullen Automotive
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating) saw a large growth in short interest in November. As of November 30th, there was short interest totalling 11,800 shares, a growth of 20.4% from the November 15th total of 9,800 shares. Based on an average trading volume of 9,000 shares, the short-interest ratio is presently 1.3 days. Currently, 0.5% of the company's stock are sold short.
Pro-Dex，Inc.(纳斯达克代码：PDEX-GET Rating)11月份在空头股数上实现了大幅增长。截至11月30日，空头股数共有11,800股，较11月15日的9,800股增长20.4%。以9,000股的平均成交量计算，目前短息比率为1.3天。目前，该公司0.5%的股票被卖空。
Pro-Dex Stock Performance
Pro-Dex股票表现
Pro-Dex stock traded up $0.41 during midday trading on Friday, reaching $17.80. 887 shares of the company's stock were exchanged, compared to its average volume of 7,985. Pro-Dex has a 52 week low of $12.40 and a 52 week high of $26.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.39 and a current ratio of 2.73. The firm has a market cap of $63.72 million, a price-to-earnings ratio of 17.12 and a beta of 0.91. The stock's 50-day simple moving average is $18.07 and its 200 day simple moving average is $17.27.
在周五午盘交易中，支持Dex的股票上涨了0.41美元，达到17.80美元。该公司股票成交量为887股，而其平均成交量为7985股。Pro-Dex的52周低点为12.40美元，52周高位为26.50美元。该公司的负债权益比率为0.41，速动比率为1.39，流动比率为2.73。该公司市值为6,372万美元，市盈率为17.12倍，贝塔系数为0.91。该股的50日简单移动均线切入位为18.07美元，200日简单移动均线切入位为17.27美元。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
Separately, StockNews.com assumed coverage on Pro-Dex in a report on Thursday. They set a "buy" rating for the company.
另外，StockNews.com在周四的一份报告中对Pro-Dex进行了报道。他们为该公司设定了“买入”评级。
Hedge Funds Weigh In On Pro-Dex
对冲基金对Pro-Dex的看法
About Pro-Dex
关于Pro-Dex
(Get Rating)
(获取评级)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Pro-Dex公司为世界各地的医疗器械原始设备制造商设计、开发、制造和销售动力手术器械。该公司提供可高压灭菌、电池供电和电动的多功能外科驱动程序和剃须刀，主要用于整形外科、胸部和颅颌面部市场。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- Which Two Bluechip Tech Companies Have Raised Their Guidance?
- Should You Worry About Elon Musk Selling His Tesla Shares?
- Can Tractor Supply Stock Surge Past Cup-With-Handle Buy Point?
- This is no Time to Buy Lennar but the Time is Coming
- Game-Changing News For Mullen Automotive
- 免费获取StockNews.com Pro-Dex上的研究报告(PDEX)
- 哪两家蓝筹科技公司提高了他们的指引？
- 你应该担心埃隆·马斯克出售他持有的特斯拉股票吗？
- 拖拉机库存能否突破杯柄收购点？
- 现在不是购买Lennar的时候，但时机即将到来
- 马伦汽车公司改变游戏规则的消息
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
接受Pro-Dex Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Pro-Dex和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧